Defining Value-Based Pricing of Drugs
JAMA
.
2018 Oct 23;320(16):1710.
doi: 10.1001/jama.2018.11808.
Authors
Michael S Broder
1
,
Jesse D Ortendahl
1
Affiliation
1
Partnership for Health Analytic Research LLC, Beverly Hills, California.
PMID:
30357288
DOI:
10.1001/jama.2018.11808
No abstract available
Publication types
Letter
Comment
MeSH terms
Costs and Cost Analysis*
Drug Costs
Economics, Pharmaceutical*